Vertex wins FDA approval for non-opioid pain drug, setting stage for closely watched rollout
Vertex Pharmaceuticals on Thursday won approval from the Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a product that has simultaneously sparked high hopes and mixed opinions among physicians and market analysts.
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a specialist in surgical and medical instruments with annual revenues of $13.55 ...
As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...
Shares of Ascentage Pharma Group International pared earlier losses to rise 0.75% in the Chinese biopharmaceutical company’s ...
Timothy Eugene Sullivan, the Chief Financial Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a $3.76 billion market ...
Latin Times on MSN9h
RFK Jr. Calls Out Bernie Sanders For Taking Money From Pharmaceutical Industry At Confirmation HearingSanders was Congress's second-largest recipient of pharmaceutical donations in 2016 yet received only individual donations ...
The industry is grappling with significant market shifts amidst emerging technologies and changing demands. Companies are now producing increasingly personalised and sophisticated therapies, ...
The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...
Donald Trump called for tariffs on foreign computer chips, semiconductors, and pharmaceuticals from places like Taiwan in the ...
Listed Tyneside pharmaceutical firm Shield Therapeutics has appointed a new CEO. The Gateshead drug discovery business, which ...
US-based pharmaceutical company 60 Degrees Pharmaceuticals has received approval from the investigational review board (IRB) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback